Literature DB >> 10799603

Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice.

C R Madden1, M J Finegold, B L Slagle.   

Abstract

Chronic infection with hepatitis B virus (HBV) is one of the major etiological factors in the development of human hepatocellular carcinoma. Transgenic mice that express the HBV X protein (HBx) have previously been shown to be more sensitive to the effects of hepatocarcinogens, although the mechanism for this cofactor role remains unknown. The ability of HBx to inhibit DNA repair in transiently transfected cell lines suggests one possible pathway. In the present study, primary hepatocytes isolated from transgenic mice that possess the HBV X gene under the control of the human alpha-1-antitrypsin regulatory region (ATX mice) were found to be deficient in their ability to conduct unscheduled DNA synthesis in response to UV-induced DNA damage. In order to measure the impact of HBx expression on DNA repair in vivo, double-transgenic mice that express HBx and possess a bacteriophage lambda transgene were sacrificed at 30, 90, and 240 days of age. Mutation frequency was determined for high-molecular-weight liver DNA of ATX and control mice by functional analysis of the lambda transgene. Expression of HBx did not significantly increase the accumulation of spontaneous mutations. These results are consistent with previous studies of HBx transgenic mice in which no effect of HBx on liver histology was apparent. This new animal model provides a powerful system in which to investigate the in vivo cooperation between HBx expression and environmental carcinogens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799603      PMCID: PMC110881          DOI: 10.1128/jvi.74.11.5266-5272.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

Review 1.  Apoptosis and carcinogenesis.

Authors:  A H Wyllie; C O Bellamy; V J Bubb; A R Clarke; S Corbet; L Curtis; D J Harrison; M L Hooper; N Toft; S Webb; C C Bird
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

2.  Recognition of DNA alterations by the mismatch repair system.

Authors:  G Marra; P Schär
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

3.  Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.

Authors:  Z Sun; P Lu; M H Gail; D Pee; Q Zhang; L Ming; J Wang; Y Wu; G Liu; Y Wu; Y Zhu
Journal:  Hepatology       Date:  1999-08       Impact factor: 17.425

4.  Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein.

Authors:  D Y Yu; H B Moon; J K Son; S Jeong; S L Yu; H Yoon; Y M Han; C S Lee; J S Park; C H Lee; B H Hyun; S Murakami; K K Lee
Journal:  J Hepatol       Date:  1999-07       Impact factor: 25.083

5.  Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells.

Authors:  I J Groisman; R Koshy; F Henkler; J D Groopman; M A Alaoui-Jamali
Journal:  Carcinogenesis       Date:  1999-03       Impact factor: 4.944

6.  Human hepatitis B virus X protein is detectable in nuclei of transfected cells, and is active for transactivation.

Authors:  T Nomura; Y Lin; D Dorjsuren; S Ohno; T Yamashita; S Murakami
Journal:  Biochim Biophys Acta       Date:  1999-03-30

7.  Hepatitis B virus X protein inhibits nucleotide excision repair.

Authors:  L Jia; X W Wang; C C Harris
Journal:  Int J Cancer       Date:  1999-03-15       Impact factor: 7.396

8.  The hepatitis B virus HBx protein inhibits caspase 3 activity.

Authors:  K Gottlob; M Fulco; M Levrero; A Graessmann
Journal:  J Biol Chem       Date:  1998-12-11       Impact factor: 5.157

9.  Hepatitis B x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes.

Authors:  S Prost; J M Ford; C Taylor; J Doig; D J Harrison
Journal:  J Biol Chem       Date:  1998-12-11       Impact factor: 5.157

Review 10.  Spontaneous mutations in the Big Blue transgenic system are primarily mouse derived.

Authors:  K A Hill; V L Buettner; B W Glickman; S S Sommer
Journal:  Mutat Res       Date:  1999-01       Impact factor: 2.433

View more
  21 in total

1.  Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions.

Authors:  C R Madden; M J Finegold; B L Slagle
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 2.  The enigmatic X gene of hepatitis B virus.

Authors:  Michael J Bouchard; Robert J Schneider
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 3.  Hepatitis B virus-induced oncogenesis.

Authors:  Joachim Lupberger; Eberhard Hildt
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

4.  Hepatitis B virus molecular biology and pathogenesis.

Authors:  R Jason Lamontagne; Sumedha Bagga; Michael J Bouchard
Journal:  Hepatoma Res       Date:  2016-07-01

5.  Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication.

Authors:  Amanda J Hodgson; Joseph M Hyser; Victor V Keasler; Yong Cang; Betty L Slagle
Journal:  Virology       Date:  2012-02-17       Impact factor: 3.616

6.  Altered DNA mutation spectrum in aflatoxin b1-treated transgenic mice that express the hepatitis B virus x protein.

Authors:  Charles R Madden; Milton J Finegold; Betty L Slagle
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

7.  Ligand selectivity and gene regulation by the human aryl hydrocarbon receptor in transgenic mice.

Authors:  Colin A Flaveny; Iain A Murray; Chris R Chiaro; Gary H Perdew
Journal:  Mol Pharmacol       Date:  2009-03-19       Impact factor: 4.436

8.  Hepatitis B virus X protein modulates apoptosis in primary rat hepatocytes by regulating both NF-kappaB and the mitochondrial permeability transition pore.

Authors:  Amy J Clippinger; Tricia L Gearhart; Michael J Bouchard
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

Review 9.  Role of HBx in hepatitis B virus persistence and its therapeutic implications.

Authors:  Betty L Slagle; Michael J Bouchard
Journal:  Curr Opin Virol       Date:  2018-02-20       Impact factor: 7.090

10.  Ah receptor represses acute-phase response gene expression without binding to its cognate response element.

Authors:  Rushang D Patel; Iain A Murray; Colin A Flaveny; Ann Kusnadi; Gary H Perdew
Journal:  Lab Invest       Date:  2009-03-30       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.